Novo to Cut Ozempic and Wegovy Prices Amid Intense Competition
Novo Nordisk announced it will slash list prices of Ozempic, Rybelsus, and Wegovy to $675 for a one-month supply starting in 2027 to help insured customers amid growing competition from Eli Lilly.